Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming

European Journal of Immunology

Volumn 30, Issue 8, 2000, Pages 2394-2403

  Gagliardi, Maria Cristina ^a   Sallusto, Federica ^b   Marinaro, Mariarosaria ^a   Langenkamp, Anja ^b   Lanzavecchia, Antonio ^b   De Magistris, Maria Teresa ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

Author keywords

Adjuvant; Cholera toxin; Dendritic cell; T cell priming

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; CHOLERA TOXIN; CYTOKINE; GLYCOPROTEIN GP 39; HLA DR ANTIGEN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CELL POLARITY; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; GERM LINE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; MUCOSAL IMMUNITY; PHENOTYPE; PRIORITY JOURNAL; TH2 CELL;

ADULT; ANTIGENS, CD80; CELL POLARITY; CHOLERA TOXIN; CYTOKINES; DENDRITIC CELLS; HLA-DR ANTIGENS; HUMANS; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; TH2 CELLS;

EID: 0033847261     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y     Document Type: Article

References (44)

1. Mucosal immunity to infection with implications for vaccine development
2. Mucosal adjuvants
3. The mechanism of cholera toxin adjuvanticity
4. The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant
5. Helper T cell subsets for immunoglobulin A responses: Oral immunization with tetanus toxoid and cholera toxin as adjurant selectively induces Th2 cells in mucosa-associated tissues
6. Mucosal adjuvant effect of cholera toxin in mice results from induction of T-helper 2 (Th2) cells and IL-4
7. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin
8. Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin
9. A non toxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity
10. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: Implications for microbial attachment and oral vaccine targeting
11. The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens
12. Cholera toxin stimulates IL-1 production and enhances antigen presentation by Mφ in vitro
13. Direct effects on antigen presenting cells and T lymphocytes explain the adjuvanticity of a nontoxic cholera toxin mutant
14. The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression
15. Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit
16. The dendritic cell system and its role in immunogenicity
17. Mucosal immunity and inflammation. I. Mucosal dendritic cells: Their specialized role in initiating T cell responses
18. Dendritic cells and the control of immunity
19. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocytes/macrophage colony stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
20. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products
21. Bacteria-induced neobiosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells
22. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA
23. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation
24. Differential regulation of chemokine receptors during dendritic cell maturation: A model for their trafficking properties
25. Selective recruitment for immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites
26. Functional diversity of helper T lymphocytes
27. Cytokines induce the development of functionally heterogeneous T helper cell subsets
28. EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is upregulated upon maturation
29. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization
30. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs
31. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses
32. Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor β1 and β2 chain expression
33. Adjuvants, a classification and review of their modes of action
34. Cholera toxin adjuvant greatly promotes antigen priming of T cells
35. Ligation of CD40 on dendritic cells triggers production of high levels of IL-12 and enhances T cell stimulatory capacity: T-T help via APC activation
36. High level of IL-12 production by murine dendritic cells: Upregulation via MHC II class and CD40 molecules and downregulation by IL-4 and IL-10
37. Distinct pattern and kinetics of chemokine production regulate dendritic cell function
38. β2-agonists prevent Th1 development by selective inhibition of interleukin 12
39. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells
40. Histamine inhibits the production of interleukin-12 through interaction with H2 receptor
41. Mucosal adjuvanticity and immunogenicity of LT-R72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity
42. A relationship between the structure and function of cholera and Escherichia coli heat-labile enterotoxins and their immunological activity at mucosal surfaces
43. Strong adjuvant properties of cholera toxin on gut mucosal responses to orally presented antigens
44. Myeloma based expression system for production of large mammalian protein